- Trials with a EudraCT protocol (103)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
103 result(s) found for: Left Pulmonary Artery.
Displaying page 1 of 6.
EudraCT Number: 2010-019352-42 | Sponsor Protocol Number: R09246M | Start Date*: 2010-08-19 | |||||||||||
Sponsor Name:Heart Center Co. Tampere University Hospital | |||||||||||||
Full Title: Effects of hypertonic saline-hydroxyethylstarch solution on extracellular water in cardiac surgery patients | |||||||||||||
Medical condition: Fifty adult male patients undergoing coronary bypass surgery will be enrolled in this study. Inclusion criteria are male gender and no need for pulmonary artery catheter (pulmonary hypertension or... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-023839-42 | Sponsor Protocol Number: H8O-CY-O027 | Start Date*: 2011-04-29 | ||||||||||||||||
Sponsor Name:General University Hospital in Prague | ||||||||||||||||||
Full Title: EXEnatide in patients undergoing Coronary artery bypass grafting for improved glUcose conTrol and hemodynamIc ValuEs | ||||||||||||||||||
Medical condition: Patients with elective coronary artery bypass grafting with LV systolic dysfunction (EF LV ≤ 50%) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: CZ (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-000771-24 | Sponsor Protocol Number: CXL-1427-02 | Start Date*: 2014-12-22 | |||||||||||
Sponsor Name:Cardioxyl Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Phase IIa Study of the Safety, Tolerability and Hemodynamic Effects of a Continuous 6-Hour Intravenous Infusion of CXL-1427 in Hospitalized Patients with Systolic Heart Failure | |||||||||||||
Medical condition: Heart failure with reduced ejection fraction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-003688-37 | Sponsor Protocol Number: KKS-243 | Start Date*: 2018-07-06 | ||||||||||||||||
Sponsor Name:Philipps-Universität Marburg | ||||||||||||||||||
Full Title: Phosphodiesterase-5 inhibition in patients with heart failure with preserved ejection fraction and combined post- and pre-capillary pulmonary hypertension (PASSION), A randomized, placebo-controll... | ||||||||||||||||||
Medical condition: Combined post- and pre-capillary pulmonary hypertension and heart failure with preserved ejection fraction | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-020153-14 | Sponsor Protocol Number: HFpEF | Start Date*: 2011-01-12 |
Sponsor Name:University Medical Center Groningen | ||
Full Title: Effects of Sildenafil on pulmonary artery pressure in patients with heart failure with preserved ejection fraction and pulmonary hypertension | ||
Medical condition: The condition to be investigated is isolated left heart failure , also called heart failure with preserved ejection fraction ( HFpEF) with pulmonary hypertension. HFpEF is a clinical syndrome wit... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-001643-21 | Sponsor Protocol Number: 2007OE002B | Start Date*: 2008-06-26 | |||||||||||
Sponsor Name:Royal Brompton and Harefield NHS Trust | |||||||||||||
Full Title: Use of endothelin-1 antagonists in patients with Established Pulmonary Hypertension and Fibrotic Lung Disease. – A randomised, placebo-controlled, double-blinded study. | |||||||||||||
Medical condition: Pulmonary hypertension in patients with interstitial lung disease. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-003181-12 | Sponsor Protocol Number: HOTPOT1 | Start Date*: 2016-10-07 |
Sponsor Name:Royal College of Surgeons in Ireland | ||
Full Title: Can sonographic assessment of pulmonary vascular reactivity following maternal hyperoxygenation therapy predict neonatal outcome in fetuses at risk of pulmonary hypertension? | ||
Medical condition: Persistent pulmonary hypertension of the newborn (PPHN) is a relatively common condition occurring in 7/1000 births and can result in significant cardiovascular instability in the newborn. It occur... | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: IE (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-003975-38 | Sponsor Protocol Number: TERPAH-001 | Start Date*: 2007-11-22 | |||||||||||
Sponsor Name:Ergonex Pharma GmbH | |||||||||||||
Full Title: Proof of Concept Study to Investigate the Efficacy, Haemodynamics and Tolerability of Terguride vs. Placebo in Patients with Pulmonary Arterial Hypertension. Double-blind, randomized, prospective P... | |||||||||||||
Medical condition: Pulmonary arterial hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) AT (Completed) NL (Completed) CZ (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-003564-31 | Sponsor Protocol Number: 190580-001 | Start Date*: 2020-01-16 | |||||||||||
Sponsor Name:Aarhus University Hospital | |||||||||||||
Full Title: Low dose catheter directed thrombolysis for acute intermediary-high risk pulmonary embolism. | |||||||||||||
Medical condition: Acute intermediary-high risk pulmonary embolism | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-005032-30 | Sponsor Protocol Number: 2021-PDNO-003 | Start Date*: 2022-05-16 | |||||||||||
Sponsor Name:Attgeno AB | |||||||||||||
Full Title: An open-label, multicenter study to evaluate the DOSE, efficacy, safety and tolerability of PDNO (Nitrosooxypropanol) infusion in patients with pulmonary hypertension after cardiopulmonary bypass (... | |||||||||||||
Medical condition: Acute Pulmonary Hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-003273-42 | Sponsor Protocol Number: 14AOI11 | Start Date*: 2014-12-23 | |||||||||||
Sponsor Name:CHU de Nice | |||||||||||||
Full Title: Comparing a diuretic vascular filling in the initial management of acute pulmonary embolism with right ventricular dysfunction normotensive | |||||||||||||
Medical condition: acute pulmonary embolism with right ventricular dysfunction normotensive | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-001210-13 | Sponsor Protocol Number: PR IOM-101 | Start Date*: 2004-11-19 |
Sponsor Name:Bracco Imaging S.p.A | ||
Full Title: MS-CTA IN PULMONARY ARTERIES FOR THE DETECTION OF PULMONARY EMBOLI AND SUBSEQUENT FOLLOW-UP MS-CTP OF THE LOWER EXTREMITY VEINS FOR THE DETECTION OF DEEP VENOUS THROMBOSIS | ||
Medical condition: SUSPECTED PULMONARY EMBOLI AND/OR DEEP VENOUS THROMBOSIS MedDRA code for deep venous thrombosis: version 7 LLT 0.913 | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-011006-42 | Sponsor Protocol Number: vs.3.23-02-2009 | Start Date*: 2009-07-13 | ||||||||||||||||
Sponsor Name:Rigshospitalet, Hjertemedicinsk afd. B | ||||||||||||||||||
Full Title: Sildenafil and diastolic dysfunction after AMI | ||||||||||||||||||
Medical condition: Diastolic dysfunction | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-005075-91 | Sponsor Protocol Number: STRATIFY-1 | Start Date*: 2018-08-30 | |||||||||||
Sponsor Name:Copenhagen University Hospital Rigshospitalet | |||||||||||||
Full Title: LOW DOSE THROMBOLYSIS, ULTRASOUND ASSISTED THROMBOLYSIS OR HEPARIN FOR INTERMEDIATE HIGH RISK PULMONARY EMBOLISM | |||||||||||||
Medical condition: Acute Pulmonary Embolism, intermediate high risk (visible impact on right ventricular structure and function, and biochemical markers og myocardial damage according to the European Society of Cardi... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-000552-25 | Sponsor Protocol Number: DS9231-A-U201 | Start Date*: 2017-08-07 | ||||||||||||||||
Sponsor Name:Daiichi Sankyo Inc. | ||||||||||||||||||
Full Title: Evaluation of Safety and Thrombolytic Effect of Ascending Doses of DS-9231 (TS23) in Subjects with Intermediate-Risk (sub-massive) Acute Pulmonary Embolism (PE) | ||||||||||||||||||
Medical condition: DS9231, also known as TS23, is an inhibitor of alpha2-antiplasmin, incrasing plasmin acitivy and enhances fibrinolysis (thrombolysis) and intended to be used for the treatment of patients with Inte... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: HU (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-003438-28 | Sponsor Protocol Number: AC-065A308 | Start Date*: 2016-03-04 | |||||||||||
Sponsor Name:Actelion Pharmaceuticals Ltd | |||||||||||||
Full Title: The efficacy and safety of initial triple versus initial dual oral combination therapy in patients with newly diagnosed pulmonary arterial hypertension: A multi-center, double-blind, placebo-cont... | |||||||||||||
Medical condition: Pulmonary arterial hypertension (PAH) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) NO (Completed) FR (Completed) DK (Completed) AT (Completed) GB (Completed) ES (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-004863-41 | Sponsor Protocol Number: SIPHT-001 | Start Date*: 2006-10-04 | |||||||||||
Sponsor Name:Dept. of Internal Medicine II, University Hospital Giessen | |||||||||||||
Full Title: Clinical investigation into efficacy, hemodynamics and tolerability of simvastatin vs placebo in patients with pulmonary arterial hypertension (Shorttitle: SIPHT) Double-blind, randomized, prospe... | |||||||||||||
Medical condition: Modified NYHA class II or III patients with Pulmonary Hypertension (PH), ICD: 416.9 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-000801-50 | Sponsor Protocol Number: TDE-PH-302 | Start Date*: 2007-02-19 | |||||||||||
Sponsor Name:United Therapeutics Corporation | |||||||||||||
Full Title: A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects with Pulmonary Arteria... | |||||||||||||
Medical condition: Idiopathic or Familial pulmonary arterial hypertension (PAH), including PAH associated with: 1) Appetite suppressant/toxin use, or 2) Repaired congenital systemic-to-pulmonary shunts (repaired ≥... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) FR (Completed) BE (Completed) NL (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-006748-76 | Sponsor Protocol Number: A1481244 | Start Date*: 2008-04-23 | |||||||||||
Sponsor Name:Pfizer Ltd. Ramsgate Road, Sandwich, Kent, UK | |||||||||||||
Full Title: A MULTINATIONAL, MULTICENTRE, RANDOMIZED, PARALLEL GROUP, DOUBLE-BLIND STUDY TO ASSESS THE EFFICACY AND SAFETY OF 1 MG, 5MG AND 20 MG TID OF ORAL SILDENAFIL IN THE TREATMENT OF SUBJECTS AGED 18 YEA... | |||||||||||||
Medical condition: Pulmonary arterial hypertension (PAH). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) DK (Prematurely Ended) BE (Completed) IT (Prematurely Ended) GR (Prematurely Ended) LV (Prematurely Ended) GB (Prematurely Ended) BG (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-003978-41 | Sponsor Protocol Number: A1481298 | Start Date*: 2016-10-13 | |||||||||||
Sponsor Name:Pfizer, Inc. | |||||||||||||
Full Title: A Phase 3, Multi-center, Open label Study To Investigate Safety, Efficacy, And Tolerability Of Sildenafil Citrate In Pediatric Patients With Pulmonary Arterial Hypertension | |||||||||||||
Medical condition: Pulmonary arterial hypertension | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.